Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GluCora is a natural health product (nutraceutical) developed by EastGate Biotech to support healthy glucose metabolism and increase insulin sensitivity. Formulated as soft gelatin capsules, it contains a highly bioavailable combination of Banaba leaf extract (standardized to 18% corosolic acid) and alpha-lipoic acid. The formulation utilizes EastGate's proprietary self-nanoemulsifying drug delivery system (SNEDDS) to enhance the solubility and absorption of these hydrophobic active ingredients. GluCora is approved in Canada under Natural Product Number (NPN) 80057426 and is intended for individuals with pre-diabetes or type 2 diabetes to help manage blood sugar levels, improve energy supply, and prevent fat deposition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GluCora.